 | Up a level |
Sarki, M and Ming, C and Aissaoui, S and Burki, N and Caiata Zufferey, Maria and Erlanger, T and Graffeo-Galbiati, R and Heinimann, K and Heinzelmann-Schwarz, V and Monnerat, C and Probst-Hensch, N and Rabaglio, M and Zürrer, U and Chappuis, P and Katapodi, M (2022) Differences in intention to inform relatives and rates of cascade testing in families concerned with hereditary breast and ovarian cancer and Lynch syndrome: The Swiss CASCADE cohort. In: European Human Genetics Conference, 11-14.6.2022, Wien.
Sarki, M and Ming, C and Aissaoui, S and Burki, N and Caiata Zufferey, Maria and Erlanger, T and Monnerat, C and Graffeo-Galbiati, R and Heinimann, K and Heinzelmann-Schwarz, V and Koechlin, H and Probst-Hensch, N and Rabaglio, M and Zürrer, U and Chappuis, P and Katapodi, M (2022) Intention to inform relatives, rates of cascade testing, and preference for patient-mediated communication in families concerned with hereditary breast and ovarian cancer and Lynch syndrome: The Swiss CASCADE cohort. Cancers, 14 (1636).
Sarki, M and Ming, C and Aceti, M and Fink, Günther and Aissaoui, S and Burki, N and Graffeo, R and Heinimann, K and Caiata Zufferey, Maria and Monnerat, C and Rabaglio, Manuela and Zürrer-Härdi, Ursina and Chappuis, P and Katapodi, M (2022) Relatives from Hereditary Breast and Ovarian Cancer and Lynch Syndrome Families Forgoing Genetic Testing: Findings from the Swiss CASCADE Cohort. Journal of Personalized Medicine, 12 (1740).